Xerofung-K Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective in the treatment of various superficial fungal infections. Ketoconazole exerts its action by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. Xerofung-K Cream is indicated for the topical management of dermatophytosis, candidiasis, pityriasis versicolor, and seborrheic dermatitis. The cream formulation allows for targeted application to affected areas, providing localized antifungal activity with minimal systemic absorption. It is typically applied once or twice daily to clean, dry skin for a duration determined by the severity and type of infection, generally ranging from 2 to 4 weeks. Patients should be advised to avoid contact with eyes and mucous membranes and to discontinue use if irritation or hypersensitivity reactions occur. Xerofung-K Cream is contraindicated in individuals with known hypersensitivity to ketoconazole or any of the cream’s excipients. As with all topical antifungals, adherence to the prescribed treatment course is essential to prevent recurrence and resistance. Consultation with a healthcare professional is recommended prior to use, especially in cases of extensive or refractory infections.